We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+1.17%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$47.1B
AUM Growth
-$899M
(-1.9%)
Cap. Flow
-$982M
Cap. Flow
% of AUM
-2.08%
Top 10 Holdings %
Top 10 Hldgs %
35.43%
Holding
967
New
122
Increased
219
Reduced
464
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$250M |
| 2 |
Starbucks
SBUX
|
+$152M |
| 3 |
CERN
Cerner Corp
CERN
|
+$122M |
| 4 |
Colgate-Palmolive
CL
|
+$87.1M |
| 5 |
Procter & Gamble
PG
|
+$77.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$456M |
| 2 |
Cisco
CSCO
|
+$392M |
| 3 |
Analog Devices
ADI
|
+$151M |
| 4 |
United Parcel Service
UPS
|
+$148M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$89.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.05% |
| 2 | Consumer Discretionary | 15.92% |
| 3 | Financials | 12.69% |
| 4 | Healthcare | 12.47% |
| 5 | Communication Services | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Monolithic Power Systems
MPWR
$68.9B
| $26.5M | 0.06% |
228,554
-8,074
| -3% | -$957K |
|
|
ARCH
152
DELISTED
Arch Resources, Inc.
ARCH
| $26.4M | 0.06% |
287,041
-32,524
| -10% | -$3.04M |
|
153
Enpro
NPO
$7.05B
| $26.4M | 0.06% |
340,732
-27,229
| -7% | -$2.25M |
|
|
KLXI
154
DELISTED
KLX Inc.
KLXI
| $26.4M | 0.06% |
439,974
-15,572
| -3% | -$910K |
|
155
Supernus Pharmaceuticals
SUPN
$2.77B
| $26.3M | 0.06% |
574,053
-20,341
| -3% | -$849K |
|
|
MDSO
156
DELISTED
Medidata Solutions, Inc.
MDSO
| $26.2M | 0.06% |
417,629
-14,143
| -3% | -$941K |
|
157
Trex
TREX
$5.01B
| $26.2M | 0.06% |
964,296
-32,424
| -3% | -$893K |
|
158
McDonald's
MCD
$195B
| $26.2M | 0.06% |
167,665
-10,665
| -6% | -$1.75M |
|
159
Lumen
LUMN
$6.44B
| $26.1M | 0.06% |
1,585,486
-717,671
| -31% | -$12.4M |
|
160
MKS Inc
MKSI
$20.6B
| $26M | 0.06% |
224,759
-88,075
| -28% | -$9.67M |
|
161
Abbott
ABT
$187B
| $26M | 0.06% |
433,613
-105,313
| -20% | -$6.35M |
|
|
WMGI
162
DELISTED
Wright Medical Group Inc
WMGI
| $25.9M | 0.05% |
1,304,665
-39,847
| -3% | -$855K |
|
163
Zoetis
ZTS
$30B
| $25.8M | 0.05% |
309,474
+47,160
| +18% | +$3.72M |
|
164
Fidelity National Financial
FNF
$13.5B
| $25.8M | 0.05% |
669,920
-65,584
| -9% | -$2.49M |
|
165
Wingstop
WING
$3.18B
| $25.6M | 0.05% |
542,181
-116,888
| -18% | -$5.37M |
|
|
CHK.PRD
166
DELISTED
Chesapeake Energy Corp. 4.5% Cum. Cnvrtbl. Prfrd. Stock
CHK.PRD
| $25.6M | 0.05% |
1,275,438
-791
| -0.1% | -$40.4K |
|
|
LOGM
167
DELISTED
LogMein, Inc.
LOGM
| $25.5M | 0.05% |
220,629
-7,819
| -3% | -$951K |
|
|
CONE
168
DELISTED
CyrusOne Inc Common Stock
CONE
| $25.5M | 0.05% |
497,162
-54,527
| -10% | -$2.92M |
|
169
Installed Building Products
IBP
$6.49B
| $25.3M | 0.05% |
420,715
-14,004
| -3% | -$931K |
|
|
BMCH
170
DELISTED
BMC Stock Holdings, Inc
BMCH
| $25.1M | 0.05% |
1,283,363
-36,980
| -3% | -$790K |
|
|
RP
171
DELISTED
RealPage, Inc.
RP
| $25M | 0.05% |
484,578
-17,126
| -3% | -$856K |
|
172
Wintrust Financial
WTFC
$10.7B
| $24.8M | 0.05% |
288,631
-12,121
| -4% | -$1.04M |
|
173
Varex Imaging
VREX
$523M
| $24.3M | 0.05% |
678,829
+46,720
| +7% | +$1.78M |
|
174
Churchill Downs
CHDN
$6.12B
| $24.1M | 0.05% |
593,172
+5,418
| +0.9% | +$230K |
|
175
American International
AIG
$41.3B
| $24.1M | 0.05% |
442,998
-49,370
| -10% | -$2.92M |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q1 2018 Portfolio in Review
As of Q1 2018, Loomis, Sayles & Company held 967 positions worth $47.1B, down 1.9% from $48B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Loomis, Sayles & Company's Q1 2018 filing shows 122 new, 219 increased, 464 reduced and 97 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 870,638 shares worth $70.6M. The largest sale was Amazon, an estimated $456M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- Loomis, Sayles & Company's largest Q1 2018 buy was BioMarin Pharmaceuticals: 870,638 shares worth $70.6M.
- Loomis, Sayles & Company added most to Regeneron Pharmaceuticals in Q1 2018, an estimated $250M increase.
- Loomis, Sayles & Company's biggest Q1 2018 reduction was Amazon, cutting an estimated $456M.
- Loomis, Sayles & Company fully exited Analog Devices in Q1 2018, selling an estimated $151M.
- Loomis, Sayles & Company's ten largest holdings make up 35% of its $47.1B portfolio in Q1 2018.
- Loomis, Sayles & Company opened 122 new positions and closed 97 in Q1 2018.
- Loomis, Sayles & Company's portfolio value fell 1.9% quarter-over-quarter to $47.1B.
Based on Loomis, Sayles & Company's 13F filing for Q1 2018, filed 11 May 2018.